PaHa02g27360

Functional evidence

eggNOG

Preferred name: BHLH130 | Seed ortholog: 337451.A0A443N5K9 | eggNOG OG: HLH@131567|pI-16, HLH@58023|Blb-23

Gene Ontology

GO:0000122 negative regulation of transcription by RNA polymerase II; GO:0000785 chromatin; GO:0000902 cell morphogenesis; GO:0000977 RNA polymerase II transcription regulatory region sequence-specific DNA binding; GO:0000978 RNA polymerase II cis-regulatory region sequence-specific DNA binding; GO:0000981 DNA-binding transcription factor activity, RNA polymerase II-specific; GO:0000987 cis-regulatory region sequence-specific DNA binding; GO:0001217 DNA-binding transcription repressor activity; GO:0001222 transcription corepressor binding; GO:0001227 DNA-binding transcription repressor activity, RNA polymerase II-specific; GO:0001228 DNA-binding transcription activator activity, RNA polymerase II-specific; GO:0001501 skeletal system development; GO:0001525 angiogenesis; GO:0001568 blood vessel development; GO:0001570 vasculogenesis; GO:0001654 eye development; GO:0001666 response to hypoxia; GO:0001701 in utero embryonic development; GO:0001708 cell fate specification; GO:0001756 somitogenesis; GO:0001757 somite specification; GO:0001889 liver development; GO:0001967 suckling behavior; GO:0002052 positive regulation of neuroblast proliferation; GO:0002076 osteoblast development; GO:0003143 embryonic heart tube morphogenesis; GO:0003150 muscular septum morphogenesis; GO:0003151 outflow tract morphogenesis; GO:0003161 cardiac conduction system development; GO:0003171 atrioventricular valve development; GO:0003180 aortic valve morphogenesis; GO:0003181 atrioventricular valve morphogenesis; GO:0003184 pulmonary valve morphogenesis; GO:0003186 tricuspid valve morphogenesis; GO:0003190 atrioventricular valve formation; GO:0003195 tricuspid valve formation; GO:0003198 epithelial to mesenchymal transition involved in endocardial cushion formation; GO:0003199 endocardial cushion to mesenchymal transition involved in heart valve formation; GO:0003203 endocardial cushion morphogenesis; GO:0003208 cardiac ventricle morphogenesis; GO:0003214 cardiac left ventricle morphogenesis; GO:0003215 cardiac right ventricle morphogenesis; GO:0003222 ventricular trabecula myocardium morphogenesis; GO:0003266 regulation of secondary heart field cardioblast proliferation; GO:0003281 ventricular septum development; GO:0003300 cardiac muscle hypertrophy; GO:0003677 DNA binding; GO:0003682 chromatin binding; GO:0003690 double-stranded DNA binding; GO:0003700 DNA-binding transcription factor activity; GO:0004565 beta-galactosidase activity; GO:0005515 protein binding; GO:0005634 nucleus; GO:0005654 nucleoplasm; GO:0005667 transcription regulator complex; GO:0005737 cytoplasm; GO:0005829 cytosol; GO:0006355 regulation of DNA-templated transcription; GO:0006357 regulation of transcription by RNA polymerase II; GO:0007155 cell adhesion; GO:0007219 Notch signaling pathway; GO:0007224 smoothened signaling pathway; GO:0007366 periodic partitioning by pair rule gene; GO:0007389 pattern specification process; GO:0007399 nervous system development; GO:0007405 neuroblast proliferation; GO:0007417 central nervous system development; GO:0007420 brain development; GO:0007422 peripheral nervous system development; GO:0007424 open tracheal system development; GO:0007435 salivary gland morphogenesis; GO:0007465 R7 cell fate commitment; GO:0007492 endoderm development; GO:0007498 mesoderm development; GO:0007507 heart development; GO:0007525 somatic muscle development; GO:0007540 sex determination, establishment of X:A ratio; GO:0008284 positive regulation of cell population proliferation; GO:0008344 adult locomotory behavior; GO:0008345 larval locomotory behavior; GO:0008432 JUN kinase binding; GO:0009047 dosage compensation by hyperactivation of X chromosome; GO:0009615 response to virus; GO:0009791 post-embryonic development; GO:0009948 anterior/posterior axis specification; GO:0009952 anterior/posterior pattern specification; GO:0009953 dorsal/ventral pattern formation; GO:0009957 epidermal cell fate specification; GO:0010460 positive regulation of heart rate; GO:0010467 gene expression; GO:0010468 regulation of gene expression; GO:0010628 positive regulation of gene expression; GO:0010629 negative regulation of gene expression; GO:0010667 negative regulation of cardiac muscle cell apoptotic process; GO:0010977 negative regulation of neuron projection development; GO:0014003 oligodendrocyte development; GO:0014015 positive regulation of gliogenesis; GO:0014019 neuroblast development; GO:0014031 mesenchymal cell development; GO:0014898 cardiac muscle hypertrophy in response to stress; GO:0016360 sensory organ precursor cell fate determination; GO:0016363 nuclear matrix; GO:0016477 cell migration; GO:0017053 transcription repressor complex; GO:0021537 telencephalon development; GO:0021555 midbrain-hindbrain boundary morphogenesis; GO:0021557 oculomotor nerve development; GO:0021558 trochlear nerve development; GO:0021575 hindbrain morphogenesis; GO:0021781 glial cell fate commitment; GO:0021794 thalamus development; GO:0021858 GABAergic neuron differentiation in basal ganglia; GO:0021861 forebrain radial glial cell differentiation; GO:0021915 neural tube development; GO:0021983 pituitary gland development; GO:0021984 adenohypophysis development; GO:0022010 central nervous system myelination; GO:0022416 chaeta development; GO:0030182 neuron differentiation; GO:0030282 bone mineralization; GO:0030324 lung development; GO:0030513 positive regulation of BMP signaling pathway; GO:0030901 midbrain development; GO:0030917 midbrain-hindbrain boundary development; GO:0031016 pancreas development; GO:0031641 regulation of myelination; GO:0032835 glomerulus development; GO:0032991 protein-containing complex; GO:0033504 floor plate development; GO:0035019 somatic stem cell population maintenance; GO:0035239 tube morphogenesis; GO:0035264 multicellular organism growth; GO:0035289 posterior head segmentation; GO:0035290 trunk segmentation; GO:0035315 hair cell differentiation; GO:0035909 aorta morphogenesis; GO:0035910 ascending aorta morphogenesis; GO:0035912 dorsal aorta morphogenesis; GO:0035914 skeletal muscle cell differentiation; GO:0036304 umbilical cord morphogenesis; GO:0036342 post-anal tail morphogenesis; GO:0042063 gliogenesis; GO:0042102 positive regulation of T cell proliferation; GO:0042462 eye photoreceptor cell development; GO:0042531 positive regulation of tyrosine phosphorylation of STAT protein; GO:0042802 identical protein binding; GO:0042803 protein homodimerization activity; GO:0042826 histone deacetylase binding; GO:0043010 camera-type eye development; GO:0043254 regulation of protein-containing complex assembly; GO:0043279 response to alkaloid; GO:0043388 positive regulation of DNA binding; GO:0043398 HLH domain binding; GO:0043425 bHLH transcription factor binding; GO:0043565 sequence-specific DNA binding; GO:0044877 protein-containing complex binding; GO:0045138 nematode male tail tip morphogenesis; GO:0045165 cell fate commitment; GO:0045466 R7 cell differentiation; GO:0045494 photoreceptor cell maintenance; GO:0045595 regulation of cell differentiation; GO:0045596 negative regulation of cell differentiation; GO:0045598 regulation of fat cell differentiation; GO:0045607 regulation of inner ear auditory receptor cell differentiation; GO:0045608 negative regulation of inner ear auditory receptor cell differentiation; GO:0045664 regulation of neuron differentiation; GO:0045665 negative regulation of neuron differentiation; GO:0045666 positive regulation of neuron differentiation; GO:0045669 positive regulation of osteoblast differentiation; GO:0045687 positive regulation of glial cell differentiation; GO:0045737 positive regulation of cyclin-dependent protein serine/threonine kinase activity; GO:0045746 negative regulation of Notch signaling pathway; GO:0045747 positive regulation of Notch signaling pathway; GO:0045840 positive regulation of mitotic nuclear division; GO:0045892 negative regulation of DNA-templated transcription; GO:0045893 positive regulation of DNA-templated transcription; GO:0045944 positive regulation of transcription by RNA polymerase II; GO:0045977 positive regulation of mitotic cell cycle, embryonic; GO:0045995 regulation of embryonic development; GO:0046331 lateral inhibition; GO:0046425 regulation of receptor signaling pathway via JAK-STAT; GO:0046427 positive regulation of receptor signaling pathway via JAK-STAT; GO:0046982 protein heterodimerization activity; GO:0048052 R1/R6 cell differentiation; GO:0048190 wing disc dorsal/ventral pattern formation; GO:0048469 cell maturation; GO:0048505 regulation of timing of cell differentiation; GO:0048511 rhythmic process; GO:0048514 blood vessel morphogenesis; GO:0048538 thymus development; GO:0048562 embryonic organ morphogenesis; GO:0048661 positive regulation of smooth muscle cell proliferation; GO:0048664 neuron fate determination; GO:0048667 cell morphogenesis involved in neuron differentiation; GO:0048708 astrocyte differentiation; GO:0048711 positive regulation of astrocyte differentiation; GO:0048712 negative regulation of astrocyte differentiation; GO:0048715 negative regulation of oligodendrocyte differentiation; GO:0048749 compound eye development; GO:0048793 pronephros development; GO:0048813 dendrite morphogenesis; GO:0048844 artery morphogenesis; GO:0048936 peripheral nervous system neuron axonogenesis; GO:0050678 regulation of epithelial cell proliferation; GO:0050683 AF-1 domain binding; GO:0050767 regulation of neurogenesis; GO:0050768 negative regulation of neurogenesis; GO:0051087 protein-folding chaperone binding; GO:0051145 smooth muscle cell differentiation; GO:0051151 negative regulation of smooth muscle cell differentiation; GO:0051216 cartilage development; GO:0055015 ventricular cardiac muscle cell development; GO:0060038 cardiac muscle cell proliferation; GO:0060042 retina morphogenesis in camera-type eye; GO:0060045 positive regulation of cardiac muscle cell proliferation; GO:0060122 inner ear receptor cell stereocilium organization; GO:0060164 regulation of timing of neuron differentiation; GO:0060173 limb development; GO:0060253 negative regulation of glial cell proliferation; GO:0060317 cardiac epithelial to mesenchymal transition; GO:0060347 heart trabecula formation; GO:0060411 cardiac septum morphogenesis; GO:0060412 ventricular septum morphogenesis; GO:0060413 atrial septum morphogenesis; GO:0060633 negative regulation of transcription initiation by RNA polymerase II; GO:0060675 ureteric bud morphogenesis; GO:0060716 labyrinthine layer blood vessel development; GO:0060766 negative regulation of androgen receptor signaling pathway; GO:0060840 artery development; GO:0060842 arterial endothelial cell differentiation; GO:0060948 cardiac vascular smooth muscle cell development; GO:0060977 coronary vasculature morphogenesis; GO:0061009 common bile duct development; GO:0061024 membrane organization; GO:0061026 cardiac muscle tissue regeneration; GO:0061106 negative regulation of stomach neuroendocrine cell differentiation; GO:0061156 pulmonary artery morphogenesis; GO:0061309 cardiac neural crest cell development involved in outflow tract morphogenesis; GO:0061626 pharyngeal arch artery morphogenesis; GO:0061629 RNA polymerase II-specific DNA-binding transcription factor binding; GO:0065003 protein-containing complex assembly; GO:0065004 protein-DNA complex assembly; GO:0070168 negative regulation of biomineral tissue development; GO:0070888 E-box binding; GO:0071347 cellular response to interleukin-1; GO:0071356 cellular response to tumor necrosis factor; GO:0071398 cellular response to fatty acid; GO:0071773 cellular response to BMP stimulus; GO:0071820 N-box binding; GO:0072012 glomerulus vasculature development; GO:0072013 glomus development; GO:0072014 proximal tubule development; GO:0072049 comma-shaped body morphogenesis; GO:0072050 S-shaped body morphogenesis; GO:0072082 specification of proximal tubule identity; GO:0072086 specification of loop of Henle identity; GO:0072087 renal vesicle development; GO:0072141 renal interstitial fibroblast development; GO:0072196 proximal/distal pattern formation involved in pronephric nephron development; GO:0072282 metanephric nephron tubule morphogenesis; GO:0090102 cochlea development; GO:0090162 establishment of epithelial cell polarity; GO:0090281 negative regulation of calcium ion import; GO:0097066 response to thyroid hormone; GO:0097084 vascular associated smooth muscle cell development; GO:0097150 neuronal stem cell population maintenance; GO:0140297 DNA-binding transcription factor binding; GO:1902692 regulation of neuroblast proliferation; GO:1904010 response to Aroclor 1254; GO:1904888 cranial skeletal system development; GO:1905934 negative regulation of cell fate determination; GO:1990090 cellular response to nerve growth factor stimulus; GO:1990837 sequence-specific double-stranded DNA binding; GO:2000227 negative regulation of pancreatic A cell differentiation; GO:2000723 negative regulation of cardiac vascular smooth muscle cell differentiation; GO:2000737 negative regulation of stem cell differentiation; GO:2000974 negative regulation of pro-B cell differentiation; GO:2000978 negative regulation of forebrain neuron differentiation; GO:2000981 negative regulation of inner ear receptor cell differentiation; GO:2001212 regulation of vasculogenesis

KEGG

KO: K06054, K06055, K09087, K09088, K09089, K09090, K09091 | Pathway: 03460, 04330, 04950, 05165, 05169, 05200, 05224 | BRITE: 00001, 03000, 03019, 03400